|
Insider Trading: Vertex Pharmaceuticals Inc / Ma
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma since year 2005. Table 2 shows the detailed insider transactions of Vertex Pharmaceuticals Inc / Ma since 2005.
The reporting company's ticker symbol is VRTX.
The reporting company's CIK number is 875320.
The total value of stock buying since 2005 is $3,011,046.
The total value of stock sales is $49,642,889.
The total value of stock exercises is $19,259,990.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Vertex Pharmaceuticals Inc / Ma (VRTX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Figure 2. Average prices of insider buys, sales, and option exercises at Vertex Pharmaceuticals Inc / Ma (VRTX) in the past 24 months. See table 2 for insider transaction details.
11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Vertex Pharmaceuticals Inc / Ma (VRTX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-10 | 0 | 0 | 4,253 | 138,860 | 4,253 | 57,968 |
| 2008-09 | 0 | 0 | 40,804 | 1,072,251 | 40,804 | 413,103 |
| 2008-08 | 0 | 0 | 62,824 | 1,784,220 | 62,824 | 640,176 |
| 2008-07 | 0 | 0 | 99,161 | 3,427,295 | 96,236 | 1,457,818 |
| 2008-06 | 0 | 0 | 3,549 | 110,196 | 8,281 | 130,301 |
| 2008-05 | 0 | 0 | 34,451 | 938,085 | 20,000 | 283,996 |
| 2008-02 | 83,710 | 1,525,579 | 0 | 0 | 12,735 | 200,385 |
| 2008-01 | 0 | 0 | 0 | 0 | 40,000 | 463,200 |
| 2007-12 | 0 | 0 | 53,175 | 1,350,568 | 52,686 | 720,217 |
| 2007-11 | 4,990 | 125,017 | 140,899 | 3,531,363 | 140,000 | 1,913,800 |
| 2007-10 | 0 | 0 | 625 | 21,742 | 625 | 8,190 |
| 2007-09 | 0 | 0 | 91,550 | 3,661,655 | 91,550 | 2,390,426 |
| 2007-08 | 0 | 0 | 31,220 | 1,093,245 | 31,220 | 397,464 |
| 2007-07 | 0 | 0 | 1,125 | 34,247 | 1,125 | 13,828 |
| 2007-06 | 50,000 | 1,322,500 | 3,000 | 88,530 | 24,105 | 294,980 |
| 2007-05 | 0 | 0 | 115,878 | 3,547,710 | 39,864 | 572,267 |
| 2007-04 | 0 | 0 | 25,925 | 813,261 | 25,625 | 363,905 |
| 2007-03 | 0 | 0 | 15,273 | 434,519 | 14,950 | 143,113 |
| 2007-02 | 0 | 0 | 41,300 | 1,358,011 | 41,000 | 590,348 |
| 2007-01 | 0 | 0 | 11,425 | 420,406 | 11,125 | 143,845 |
| 2006-12 | 0 | 0 | 88,054 | 3,525,963 | 83,144 | 1,162,528 |
| 2006-11 | 0 | 0 | 86,274 | 3,808,439 | 52,686 | 840,477 |
| 2006-10 | 0 | 0 | 46,370 | 1,686,545 | 46,070 | 742,612 |
| 2006-09 | 0 | 0 | 23,500 | 808,095 | 23,500 | 370,025 |
| 2006-08 | 0 | 0 | 107,500 | 3,488,828 | 94,500 | 1,170,245 |
| 2006-07 | 0 | 0 | 63,460 | 2,251,011 | 63,460 | 813,041 |
| 2006-06 | 0 | 0 | 41,880 | 1,408,346 | 41,880 | 475,252 |
| 2006-05 | 455 | 14,550 | 49,416 | 1,698,660 | 46,500 | 542,886 |
| 2006-04 | 0 | 0 | 37,820 | 1,373,664 | 37,820 | 412,747 |
| 2006-03 | 650 | 23,400 | 50,441 | 2,088,486 | 45,308 | 530,571 |
| 2006-02 | 0 | 0 | 49,118 | 1,778,206 | 42,806 | 537,689 |
| 2006-01 | 0 | 0 | 30,645 | 1,029,048 | 29,432 | 462,587 |
| 2005-12 | 0 | 0 | 30,938 | 856,200 | 0 | 0 |
| 2005-11 | 0 | 0 | 600 | 15,234 | 0 | 0 |
Go to page: 1
2
Table 2. Detailed insider stock purchases, sales, and option exercises
for Vertex Pharmaceuticals Inc / Ma (VRTX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-10-01 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 4,253 | 32.65 | 138,860 |
| 2008-10-01 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 4,253 | 13.63 | 57,968 |
| 2008-09-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 27.94 | 67,056 |
| 2008-09-17 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.07 | 21,768 |
| 2008-09-10 | Boger Joshua S (President & CEO) | Sale | 12,778 | 26.54 | 339,192 |
| 2008-09-10 | Boger Joshua S (President & CEO) | Option Exercise | 12,778 | 10.19 | 130,207 |
| 2008-09-10 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 6,614 | 26.23 | 173,485 |
| 2008-09-10 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 6,614 | 10.19 | 67,396 |
| 2008-09-03 | Boger Joshua S (President & CEO) | Sale | 12,400 | 25.93 | 321,532 |
| 2008-09-03 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-09-03 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 6,612 | 25.86 | 170,986 |
| 2008-09-03 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 6,612 | 10.19 | 67,376 |
| 2008-08-27 | Boger Joshua S (President & CEO) | Sale | 12,400 | 27.03 | 335,172 |
| 2008-08-27 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-08-27 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 6,612 | 27.02 | 178,656 |
| 2008-08-27 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 6,612 | 10.19 | 67,376 |
| 2008-08-20 | Boger Joshua S (President & CEO) | Sale | 12,400 | 27.39 | 339,677 |
| 2008-08-20 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-08-20 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 6,612 | 27.70 | 183,119 |
| 2008-08-20 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 6,612 | 10.19 | 67,376 |
| 2008-08-13 | Boger Joshua S (President & CEO) | Sale | 12,400 | 29.36 | 364,064 |
| 2008-08-13 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-08-06 | Boger Joshua S (President & CEO) | Sale | 12,400 | 30.93 | 383,532 |
| 2008-08-06 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-07-30 | Boger Joshua S (President & CEO) | Sale | 12,400 | 32.64 | 404,798 |
| 2008-07-30 | Boger Joshua S (President & CEO) | Option Exercise | 12,400 | 10.19 | 126,356 |
| 2008-07-21 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 2,925 | 32.30 | 94,477 |
| 2008-07-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 2,400 | 32.40 | 77,760 |
| 2008-07-15 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Option Exercise | 2,400 | 9.07 | 21,768 |
| 2008-07-09 | Smith Ian F (EVP & CFO) | Sale | 81,436 | 35.00 | 2,850,260 |
| 2008-07-09 | Smith Ian F (EVP & CFO) | Option Exercise | 81,436 | 16.08 | 1,309,694 |
| 2008-06-19 | Alam John J (EVP, Med. Dev. Group & CMO) | Option Exercise | 8,281 | 15.74 | 130,301 |
| 2008-06-05 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 3,549 | 31.05 | 110,196 |
| 2008-05-27 | Brimblecombe Roger W (Director) | Sale | 3,333 | 26.75 | 89,150 |
| 2008-05-27 | Brimblecombe Roger W (Director) | Option Exercise | 3,333 | 14.20 | 47,328 |
| 2008-05-27 | Sanders Charles A (Director) | Sale | 3,333 | 26.75 | 89,150 |
| 2008-05-27 | Sanders Charles A (Director) | Option Exercise | 3,333 | 14.20 | 47,328 |
| 2008-05-21 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 80 | 27.89 | 2,231 |
| 2008-05-20 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 1,512 | 27.59 | 41,716 |
| 2008-05-20 | Garrison Richard C (SVP and Catalyst) | Sale | 727 | 27.63 | 20,086 |
| 2008-05-20 | Brimblecombe Roger W (Director) | Sale | 3,333 | 27.61 | 92,019 |
| 2008-05-20 | Brimblecombe Roger W (Director) | Option Exercise | 3,333 | 14.20 | 47,328 |
| 2008-05-20 | Smith Ian F (EVP & CFO) | Sale | 930 | 27.63 | 25,692 |
| 2008-05-20 | Alam John J (EVP, Med. Dev. Group & CMO) | Sale | 722 | 27.60 | 19,928 |
| 2008-05-20 | Sanders Charles A (Director) | Sale | 3,333 | 27.59 | 91,961 |
| 2008-05-20 | Sanders Charles A (Director) | Option Exercise | 3,333 | 14.20 | 47,328 |
| 2008-05-13 | Graves Kurt (EVP, Chief Commercial Officer) | Sale | 951 | 27.26 | 25,927 |
| 2008-05-13 | Garrison Richard C (SVP and Catalyst) | Sale | 2,258 | 27.19 | 61,401 |
| 2008-05-13 | Mueller Peter (EVP Drug Innov.& Realiz, CSO) | Sale | 1,541 | 27.11 | 41,775 |
| 2008-05-13 | Brimblecombe Roger W (Director) | Sale | 3,334 | 27.21 | 90,708 |
| 2008-05-13 | Brimblecombe Roger W (Director) | Option Exercise | 3,334 | 14.20 | 47,342 |
| 2008-05-13 | Smith Ian F (EVP & CFO) | Sale | 5,730 | 27.16 | 155,609 |
| 2008-05-13 | Sanders Charles A (Director) | Sale | 3,334 | 27.21 | 90,732 |
| 2008-05-13 | Sanders Charles A (Director) | Option Exercise | 3,334 | 14.20 | 47,342 |
| 2008-02-15 | Sachs Bruce I (Director) | Purchase | 58,710 | 18.09 | 1,062,240 |
| 2008-02-15 | Ullian Elaine (Director) | Purchase | 3,000 | 18.08 | 54,239 |
| 2008-02-14 | Sachs Bruce I (Director) | Purchase | 20,000 | 18.57 | 371,350 |
| 2008-02-14 | Ullian Elaine (Director) | Purchase | 1,000 | 18.75 | 18,750 |
| 2008-02-13 | Ullian Elaine (Director) | Purchase | 1,000 | 19.00 | 19,000 |
| 2008-02-12 | Boger Joshua S (President & CEO) | Option Exercise | 12,735 | 15.74 | 200,385 |
| 2008-01-07 | Sachs Bruce I (Director) | Option Exercise | 40,000 | 11.58 | 463,200 |
| 2007-12-12 | Power Johanna Messina (VP & Controller) | Sale | 9 | 25.43 | 228 |
| 2007-12-11 | Alam John J (EVP, Medicines Dev. & CMO) | Sale | 480 | 25.63 | 12,303 |
| 2007-12-07 | Boger Joshua S (President & CEO) | Sale | 17,686 | 25.65 | 453,570 |
| 2007-12-07 | Boger Joshua S (President & CEO) | Option Exercise | 17,686 | 13.67 | 241,767 |
| 2007-12-06 | Boger Joshua S (President & CEO) | Sale | 17,500 | 25.59 | 447,877 |
| 2007-12-06 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-12-04 | Boger Joshua S (President & CEO) | Sale | 17,500 | 24.95 | 436,590 |
| 2007-12-04 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-29 | Boger Joshua S (President & CEO) | Sale | 17,500 | 24.95 | 436,555 |
| 2007-11-29 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-27 | Boger Joshua S (President & CEO) | Sale | 17,500 | 24.09 | 421,627 |
| 2007-11-27 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-21 | Boger Joshua S (President & CEO) | Sale | 17,500 | 23.39 | 409,390 |
| 2007-11-21 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-20 | Boger Joshua S (President & CEO) | Sale | 17,500 | 24.85 | 434,828 |
| 2007-11-20 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-16 | Garrison Richard C (SVP, Catalyst) | Sale | 627 | 25.97 | 16,285 |
| 2007-11-16 | Power Johanna Messina (VP & Controller) | Sale | 271 | 26.01 | 7,047 |
| 2007-11-16 | Alam John J (EVP, Medicines Dev. & CMO) | Sale | 1 | 25.82 | 25 |
| 2007-11-15 | Boger Joshua S (President & CEO) | Sale | 17,500 | 26.50 | 463,720 |
| 2007-11-15 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-13 | Boger Joshua S (President & CEO) | Sale | 17,500 | 25.84 | 452,238 |
| 2007-11-13 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-08 | Boger Joshua S (President & CEO) | Sale | 17,500 | 25.45 | 445,311 |
| 2007-11-08 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-11-07 | Sachdev Amit (SVP, Public Policy,Gov Affairs) | Purchase | 1,000 | 24.72 | 24,720 |
| 2007-11-06 | Graves Kurt (EVP, Chief Commercial Officer) | Purchase | 3,990 | 25.14 | 100,297 |
| 2007-11-06 | Boger Joshua S (President & CEO) | Sale | 17,500 | 25.39 | 444,337 |
| 2007-11-06 | Boger Joshua S (President & CEO) | Option Exercise | 17,500 | 13.67 | 239,225 |
| 2007-10-29 | Power Johanna Messina (VP & Controller) | Sale | 125 | 32.44 | 4,054 |
| 2007-10-29 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-10-22 | Power Johanna Messina (VP & Controller) | Sale | 125 | 30.23 | 3,778 |
| 2007-10-22 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-10-15 | Power Johanna Messina (VP & Controller) | Sale | 125 | 36.05 | 4,506 |
| 2007-10-15 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-10-08 | Power Johanna Messina (VP & Controller) | Sale | 125 | 36.47 | 4,558 |
| 2007-10-08 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-10-01 | Power Johanna Messina (VP & Controller) | Sale | 125 | 38.77 | 4,846 |
| 2007-10-01 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-09-24 | Power Johanna Messina (VP & Controller) | Sale | 125 | 38.21 | 4,776 |
| 2007-09-24 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-09-19 | Power Johanna Messina (VP & Controller) | Sale | 200 | 40.00 | 8,000 |
| 2007-09-19 | Power Johanna Messina (VP & Controller) | Option Exercise | 200 | 13.11 | 2,622 |
| 2007-09-17 | Power Johanna Messina (VP & Controller) | Sale | 50 | 40.04 | 2,002 |
| 2007-09-17 | Power Johanna Messina (VP & Controller) | Option Exercise | 50 | 13.11 | 655 |
| 2007-09-10 | Power Johanna Messina (VP & Controller) | Sale | 125 | 39.60 | 4,950 |
| 2007-09-10 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-09-05 | Smith Ian F (EVP & CFO) | Sale | 90,925 | 40.00 | 3,637,000 |
| 2007-09-05 | Smith Ian F (EVP & CFO) | Option Exercise | 90,925 | 26.20 | 2,382,235 |
| 2007-09-04 | Power Johanna Messina (VP & Controller) | Sale | 125 | 39.42 | 4,927 |
| 2007-09-04 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-08-27 | Power Johanna Messina (VP & Controller) | Sale | 125 | 37.31 | 4,663 |
| 2007-08-27 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-08-20 | Power Johanna Messina (VP & Controller) | Sale | 125 | 36.26 | 4,532 |
| 2007-08-20 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-08-13 | Power Johanna Messina (VP & Controller) | Sale | 125 | 36.12 | 4,515 |
| 2007-08-13 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-08-06 | Power Johanna Messina (VP & Controller) | Sale | 125 | 34.68 | 4,335 |
| 2007-08-06 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-08-06 | Alam John J (EVP, Medicines Dev. & CMO) | Sale | 30,720 | 35.00 | 1,075,200 |
| 2007-08-06 | Alam John J (EVP, Medicines Dev. & CMO) | Option Exercise | 30,720 | 12.72 | 390,912 |
| 2007-07-30 | Power Johanna Messina (VP & Controller) | Sale | 125 | 32.46 | 4,057 |
| 2007-07-30 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 13.11 | 1,638 |
| 2007-07-25 | Power Johanna Messina (VP & Controller) | Sale | 1,000 | 30.19 | 30,190 |
| 2007-07-25 | Power Johanna Messina (VP & Controller) | Option Exercise | 1,000 | 12.19 | 12,190 |
| 2007-06-26 | Sachs Bruce I (Director) | Purchase | 50,000 | 26.45 | 1,322,500 |
| 2007-06-18 | Boger Joshua S (President & CEO) | Option Exercise | 7,626 | 13.11 | 99,976 |
| 2007-06-08 | Boger Joshua S (President & CEO) | Option Exercise | 13,479 | 11.93 | 160,804 |
| 2007-06-04 | Hartmann Victor A (EVP, Strategic & Corp. Devlp.) | Sale | 3,000 | 29.51 | 88,530 |
| 2007-06-04 | Hartmann Victor A (EVP, Strategic & Corp. Devlp.) | Option Exercise | 3,000 | 11.40 | 34,200 |
| 2007-05-29 | Slater Eve Elizabeth (Director) | Sale | 10,000 | 30.42 | 304,200 |
| 2007-05-29 | Slater Eve Elizabeth (Director) | Option Exercise | 10,000 | 13.32 | 133,200 |
| 2007-05-29 | Power Johanna Messina (VP & Controller) | Sale | 125 | 30.49 | 3,811 |
| 2007-05-29 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 11.27 | 1,408 |
| 2007-05-21 | Power Johanna Messina (VP & Controller) | Sale | 125 | 31.56 | 3,945 |
| 2007-05-21 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 11.27 | 1,408 |
| 2007-05-17 | Hartmann Victor A (EVP, Strategic & Corp. Devlp.) | Sale | 824 | 31.95 | 26,326 |
| 2007-05-17 | Garrison Richard C (SVP, Catalyst) | Sale | 632 | 31.95 | 20,192 |
| 2007-05-17 | Smith Ian F (EVP & CFO) | Sale | 823 | 31.95 | 26,294 |
| 2007-05-17 | Power Johanna Messina (VP & Controller) | Sale | 220 | 31.95 | 7,029 |
| 2007-05-17 | Alam John J (EVP, Medicines Dev. & CMO) | Sale | 794 | 31.95 | 25,368 |
| 2007-05-14 | Power Johanna Messina (VP & Controller) | Sale | 125 | 30.05 | 3,756 |
| 2007-05-14 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 11.27 | 1,408 |
| 2007-05-07 | Mueller Peter (CSO&EVP Drug Innov&Realization) | Sale | 11,401 | 30.59 | 348,756 |
| 2007-05-07 | Smith Ian F (EVP & CFO) | Sale | 32,500 | 30.61 | 994,825 |
| 2007-05-07 | Power Johanna Messina (VP & Controller) | Sale | 125 | 30.67 | 3,833 |
| 2007-05-07 | Power Johanna Messina (VP & Controller) | Option Exercise | 125 | 11.22 | 1,403 |
| 2007-05-07 | Alam John J (EVP, Medicines Dev. & CMO) | Sale | 32,500 | 30.59 | 994,175 |
| 2007-05-07 | Alam John J (EVP, Medicines Dev. & CMO) | Option Exercise | 16,364 | 12.31 | 201,440 |
Go to page: 1
2
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX,
CIK number 875320) see
the Securities and Exchange Commission (SEC) website.
|
|
